Mirae Asset Global ETFs Holdings’s Charles River Laboratories CRL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$712K	Hold	3,139	–	–	﹤0.01%	1808
2026 Q1	$541K	Buy	3,139 +26	+0.8%	+$4.82K	﹤0.01%	1856
2025 Q4	$621K	Sell	3,113 -551	-15%	-$99.9K	﹤0.01%	1783
2025 Q3	$573K	Sell	3,664 -106	-3%	-$16.8K	﹤0.01%	1804
2025 Q2	$572K	Sell	3,770 -403	-10%	-$53.7K	﹤0.01%	1755
2025 Q1	$628K	Buy	4,173 +42	+1%	+$7.04K	﹤0.01%	1748
2024 Q4	$763K	Buy	4,131 +105	+3%	+$20.2K	﹤0.01%	1695
2024 Q3	$793K	Sell	4,026 -15	-0.4%	-$3.12K	﹤0.01%	1669
2024 Q2	$835K	Buy	+4,041	New	+$916K	﹤0.01%	1555

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CRL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings held its Charles River Laboratories (CRL) position steady in Q2 2026 at 3,139 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #1808.

Mirae Asset Global ETFs Holdings first reported a position in CRL in Q2 2024 and has held it in 9 quarters since. The position peaked at $835K in Q2 2024. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Mirae Asset Global ETFs Holdings held 3,139 shares of Charles River Laboratories worth $712K as of Q2 2026.
Mirae Asset Global ETFs Holdings left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1808 holding.
Mirae Asset Global ETFs Holdings first reported a position in Charles River Laboratories in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Charles River Laboratories position peaked at $835K in Q2 2024.
565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.